It is known that continuing smoking during the cancer treatments worsens the prognosis [44–46], possibly due to the fact that resistance to CS involves some of the same mechanisms, as the development of resistance to drugs, one of those being an increase in ABCG2 [38]. This evidence concerns the gene ABCG2 and cancer.